Search results
Results from the WOW.Com Content Network
USA Today. Lange, Tony (April 20, 2024), "Federal Cannabis Legalization and Reform: Where Are We in 2024?", Cannabis Business Times; David A. Lieb (May 4, 2024). "As the US moves to reclassify marijuana as a less dangerous drug, could more states legalize it?". Associated Press News.
Medical and recreational marijuana are already legal in the state. Question 4 asks voters about legislation that would allow the following: Possession, growing and use of "certain natural ...
Despite pro-marijuana groups spending millions, voters in red and blue states rejected marijuana and psychedelic legalization ballot measures, indicating that drug legalization is unpopular and ...
NORML also has a sister organization, NORML Foundation, that focuses on educational efforts and providing legal assistance and support to people affected negatively by current marijuana laws. [2] NORML maintains chapters in a number of US states as well as outside the US in countries such as Canada, France, New Zealand, and South Africa.
Even the New York Times editorial board, which acknowledged marijuana's medical potential, thought the Clinton administration had "little choice but to insist that Federal drug statutes be enforced."
The year 2023 began with several state efforts to legalize adult-use or medical cannabis, despite an apparently stalled federal effort to do so. [1] A cannabis industry executive predicted that at least two states would enact adult-use reform in 2023, with the most likely states to legalize being Minnesota, Pennsylvania and Ohio. [2]
The Biden administration plans to reclassify marijuana for the first time since the Controlled Substances Act was enacted more than 50 years ago. DEA to reclassify marijuana, easing restrictions ...
In 1972 the National Organization for the Reform of Marijuana Laws (NORML) petitioned the Bureau of Narcotics and Dangerous Drugs (BNDD) (now the Drug Enforcement Administration (DEA)) to transfer cannabis to Schedule II so that it could be legally prescribed by physicians. The BNDD declined to initiate proceedings on the basis of their ...